Simultaneous square-wave voltammetric determination of riboflavin and folic acid in pharmaceutical preparations

The square-wave voltammetric (SWV) behaviour of riboflavin and folic acid was studied at a static mercury drop electrode by square wave voltammetry. In 0.05M KCl (pH 5.89) a cathodic scan gave peaks at — 0.56 and — 0.87 V vs. Ag/AgCl for riboflavin and folic acid, respectively. The reduction peak currents are linearly dependent on the concentration of vitamins. Both vitamins can be simultaneously determined from the same voltammogram. The method proposed for the determination of riboflavin and folic acid in multivitamin tablets is very simple, rapid and does not involve time-consuming separation steps. The average contents of riboflavin and folic acid were found to be 14.8 ± 1.26% and 1.46 ± 2.66%, for tablet A and 9.86 ±1.40% and 1.47 ± 2.0% for tablet B, respectively.     

Use of adsorptive square-wave anodic stripping voltammetry at carbon paste electrode for the determination of amlodipine besylate in pharmaceutical preparations

The antihypertensive drug amlodipine has been characterized voltammetrically in a carbon paste electrode by means of anodic stripping voltammetry. An adsorptive stripping method in a carbon paste electrode for trace determination of amlodipine has been described. Cyclic voltammetric studies indicated the oxidation of amlodipine besylate at the electrode surface through a single two-electron irreversible step fundamentally controlled by adsorption. A study of the variation in the peak current with solution variables such as pH, ionic strength, concentration of amlodipine, possible interference, and instrumental variables, such as preconcentration time and accumulation potential, has resulted in the optimization of the oxidation signal for analytical purposes. By anodic adsorptive anodic stripping voltammetry, the calibration plot was linear in the range 9.9 × 10^?9 ? 1.4 × 10^?7 M with a detection limit of 2 × 10^?10 M in a carbon paste electrode at pH 11.0. The procedure was successfully applied to the assay of amlodipine besylate in some commercial products in the market (Amlopres®, Amlodipine, and Norvasc®). The percentage recoveries were in agreement with those obtained by the reference method.     

Simultaneous determination of ofloxacin and ornidazole in pharmaceutical preparations by capillary zone electrophoresis

A simple, rapid and validated capillary electrophoretic method has been developed for the separation and determination of ofloxacin and ornidazole in pharmaceutical formulations with detection at 230 nm. Optimal conditions for the quantitative separations were investigated. Analysis times shorter than 4 min were obtained using a background electrolyte solution consisting of 25 mmol/L phosphoric acid adjusted with 1 m Tris buffer to pH 8.5, with hydrodynamic injection of 5 s and 20 kV separation voltage. The validation criteria for accuracy, precision, linearity and limits of detection and quantitation were examined and discussed. An excellent linearity was obtained in concentration range 25–250 µg/mL. The detection limits for ofloxacin and ornidazole were 1.03 ± 0.11 and 1.80 ± 0.06 µg/mL, respectively. The proposed method has been applied for the analysis of ofloxacin and ornidazole both individually and in a combined dosage tablet formulation. The proposed validated method showed recoveries between 96.16 and 105.23% of the nominal contents. Copyright © 2009 John Wiley & Sons, Ltd.     

Flow-injection chemiluminescence determination of ofloxacin and levofloxacin in pharmaceutical preparations and biological fluids.

A novel, rapid and sensitive analytical method is described for determination of ofloxacin and levofloxacin by enhanced chemiluminescence (CL) with flow-injection sampling. The method is based on the CL reaction of the Ce(IV)-Na2S2O4-ofloxacin/levofloxacin-H2SO2 system. The enhanced CL mechanism was developed and the optimum conditions for CL emission were investigated. The CL intensity was correlated linearly (r = 0.9988) with the concentration of ofloxacin (or levofloxacin) in the range of 1.0 x 10(-8) - 1.0 x 10(-7) g ml(-1) and 1.0 x 10(-7) - 6.0 x 10(-6) g ml(-1). The detection limit (S/N = 3) is 7 x 10(-9) g ml(-1). The relative standard derivation (RSD, n = 11) is 2.0% for ofloxacin at 4 x 10(-7) g ml(-1) and for levofloxacin at 6 x 10(-7) g ml(-1). This method has been successfully applied for the determination of ofloxacin and levofloxacin in pharmaceutical preparations and biological fluids with satisfactory results.     

Electrochemical behavior of thiamine on a self-assembled gold electrode and its square-wave voltammetric determination in pharmaceutical preparations.

The electrochemical behavior of thiamine on a self-assembled electrode of L-cysteine (Cys/SAM/Au) has been investigated and Cys/SAM/Au can be used to detect thiamine using square-wave voltammetry (SWV). At pH 11.40 Britton-Robinson buffer, thiamine exhibits a well-defined anodic peak on Cys/SAM/Au. Under the optimized conditions, the anodic peak current of SWV was linear with the content of thiamine in the range of 1.1 x 10(-8) - 2.2 x 10(-6) mol/L; the detection limit was 5.5 x 10(-9) mol/L. The method was successfully applied to the determination of thiamine in pharmaceutical preparations.     

Electrochemical determination of rosiglitazone by square-wave adsorptive stripping voltammetry method

Square-wave adsorptive stripping voltammetry technique was used to determine rosiglitazone (ROS) on the hanging mercury dropping electrode (HMDE) surface, in Britton Robinson buffer, pH = 5. The voltammetric cathodic peak was observed at ?1520 mV vs. Ag/AgCl reference electrode. The voltammetric peak response was characterized with respect to pH, supporting electrolyte, accumulation potential, preconcentration time, scan rate, frequency, pulse amplitude, surface area of the working electrode and the convection rate. Under optimal conditions, the voltammetric current is proportional to the concentration of ROS over the concentration range of 5 × 10^?8–8 × 10^?7 mol l^?1 (r = 0.9899) with a detection limit of 3.2 × 10^?11 mol l^?1 using 120 s accumulation time. The developed SW-AdSV procedure showed a good reproducibility, the relative standard deviation RSD% (n = 10) at a concentration level of 5 × 10^?7 mol l^?1 was 0.33%, whereas the accuracy was 101% ± 1.0. The proposed method was successfully applied to assay the drug in the human urine and plasma samples with mean recoveries of 90 ± 0.71% and 86 ± 1.0%, respectively.     

Simultaneous square-wave voltammetric determination of acetazolamide and theophylline in pharmaceutical formulations

Simple, rapid, sensitive and low cost voltammetric method for simultaneous determination of acetazolamide and theophylline in pharmaceutical formulations, was developed using a static mercury drop electrode (SMDE). Well-defined voltammetric peaks were obtained at–0.87 and–1.33 V for acetazolamide and–0.21 V (vs. Ag/AgCl) for theophylline in Britton–Robinson (B–R) buffer (pH 2.4). The reduction peak currents are found to be linearly dependent on the concentration for the both drugs. Calibration graphs were obtained over the concentration range 1.98 × 10^–6 to 5.94 × 10^–5 M and 2.0 × 10^–5 to 5.6 × 10^–4 M for acetazolamide and theophylline, respectively. The limits of detection (LOD) and quantitation (LOQ) of the procedure were also presented. Factors such as, pH of supporting electrolyte, equilibrium time, frequency, scan rate and pulse height were optimized. The validated voltammetric method was successfully applied for simultaneous determinations of the two drugs. The procedure does not require any sample pretreatment or timeconsuming separation steps.     

Cathodic stripping voltammetry of pipemidic acid and ofloxacin in pharmaceutical dosages and human urine

Sensitive cathodic stripping voltammetric methods have been developed for two quinolone antibacterial drugs, pipemidic acid (PIP) and ofloxacin (OFL) using hanging mercury drop electrode as working electrode vs. Ag/AgCl reference electrode. The methods were developed for the determination of drugs individually as well as simultaneously. 0.1 M and 0.01 M hydrochloric acid was used as medium for PIP and OFL, respectively, 0.1 M potassium chloride was used as base electrolyte. Reduction waves were observed for PIP within ?700 mV to ?800 mV and for OFL within ?1100 mV to ?1200 mV. Linear calibration ranges for PIP and OFL were observed within 10–100 μg ml^?1 with detection limits of 50 ng ml^?1 and 1 μg ml^?1, respectively. Relative standard deviations (RSD) for the analysis of 10 gµg ml^?1 of PIP and OFL (n = 6) were 0.5% and 1.4%, respectively. The presence of glucose, lactose, sorbitol, gum arabic, starch, magnesium stearate, methylparaben and propylparaben did not affect the determinations of both PIP and OFL. The methods were used for the analysis of pharmaceutical preparations and the results indicated relative deviation of 0.5–5.5% from labeled values with RSD within 0.49–2.5%. PIP and OFL could also be determined simultaneously, and were determined from spiked human urine.     

Electrochemical studies and square-wave voltammetric determination of fenofibrate in pharmaceutical formulations

The electrochemical reduction of fenofibrate at a hanging mercury drop electrode (HMDE) was investigated by cyclic voltammetry, square-wave voltammetry, and chronoamperometry. Different buffer solutions were used over a wide pH range (3.0–10.0). The best definition of the analytical signals was found in borate buffer (pH 9.0)–tetrabutylammonium iodide mixture containing 12.5% (v/v) methanol at –1.2 V (versus Ag/AgCl). According to cyclic voltammetric studies, the reduction was irreversible and diffusion controlled. The diffusion coefficient was 2.38×10^–6 cm² s^–1 as determined by chronoamperometry. Under optimized conditions of square-wave voltammetry, a linear relationship was obtained between 0.146–4.96 g mL^–1 of fenofibrate with a limit of detection of 0.025 g mL^–1. Validation parameters such as sensitivity, accuracy, precision, and recovery were evaluated. The proposed method was applied to the determination of fenofibrate in pharmaceutical formulations. The results were compared with those obtained by a published high-performance liquid chromatography method. No difference was found statistically.     

Direct determination of molybdenum in seawater by adsorption cathodic stripping square-wave voltammetry

A reliable and very sensitive procedure for the determination of trace levels of molybdenum in seawater is proposed. The complex of molybdenum with 8-hydroxyquinoline (Oxine) is analyzed by cathodic stripping square-wave voltammetry based on the adsorption collection onto a hanging mercury drop electrode (HMDE). This procedure of molybdenum determination was found to be more favorable than differential pulse cathodic stripping voltammetry because of inherently faster scan rate and much better linearity obtained through the one-peak (instead of one-of-two peaks) calibration. The variation of polarographic peak and peak current with a pH, adsorption time, adsorption potential, and some instrumental parameters such as scan rate and pulse height were optimized. The alteration of polarographic wave and its likely mechanism are also discussed. The relationship between peak current and molybdenum concentration is linear up to 150 mug l(-1). Under the optimal analytical conditions, the determination limit of 0.5 mug l(-1) Mo was reached after 60 s of the stirred collection. The estimated detection limit is better than 0.1 mug l(-1) of Mo. The applicability of this method to analysis of seawater was assessed by the determination of molybdenum in two certified reference seawater samples (CASS-2 and NASS-2) and the comparison of the analytical results for real seawater samples (study on a vertical distribution of Mo in the seawater column) with the results obtained by Zeeman-corrected electrothermal atomization atomic absorption spectrometry (Zeeman ETAAS). A good agreement between two used methods of molybdenum determination was obtained.     

Polarographic determination of loratadine in pharmaceutical preparations

Loratadine, a potent antihistamine drug, is not directly electroreducible at a dropping mercury electrode; however, by means of a nitration procedure it is possible to obtain a nitro-loratadine derivative which has been identified as 4-(8-chloro-7-nitro-5,6-dihydro-11 H-benzo-[5,6]-cyclohepta-[l,2-b]-pyridin-l l-ylidene)-1-piperidine carboxylic acid ethyl ester. The electrochemical reduction of this derivative at different pHs and concentrations using polarography and cyclic voltammetry was studied. The derivative exhibits a differential pulse polarographic peak due to the reduction of the nitro group. This peak was used in order to develop an analytical procedure for determining loratadine in pharmaceutical dosage forms.

The recovery study shows adequate accuracy and precision for the developed assay and the excipients do not interfere in the determination.     

Kinetic determination of codeine in pharmaceutical preparations

A kinetic method for the determination of codeine, based on its inhibitor action on the catalytic decomposition of hydrogen peroxide by cobalt(II), is presented. It has been found that the effect of codeine is most pronounced in the presence of 5% v/v ethylene glycol. The reaction is followed photometrically. Codeine can be determined in concentrations ranging from 0.80×10^–5 M to 2.4×10^–5 M. The method has been applied to the determination of codeine in pharmaceutical preparations.     

Polarographic determination of chlorquinaldol in pharmaceutical preparations

A polarographic method for chlorquinaldol (5,7-dichloro-2-methyl-8-hydroxyquinoline) determination, based on the main cathodic wave, has been developed in acidic medium and it has been applied to pharmaceutical preparations. The obtained results show good accuracy; the relative standard deviation is ± 0.013.     

Spectrofluorimetric determination of fluoroquinolones in pharmaceutical preparations

Simple, rapid and highly sensitive spectrofluorimetric method is presented for the determination of four fluoroquinolone (FQ) drugs, ciprofloxacin, enoxacin, norfloxacin and moxifloxacin in pharmaceutical preparations. Proposed method is based on the derivatization of FQ with 4-chloro-7-nitrobenzofurazan (NBD-Cl) in borate buffer of pH 9.0 to yield a yellow product. The optimum experimental conditions have been studied carefully. Beer's law is obeyed over the concentration range of 23.5-500 ng mL(-1) for ciprofloxacin, 28.5-700 ng mL(-1) for enoxacin, 29.5-800 ng mL(-1) for norfloxacin and 33.5-1000 ng mL(-1) for moxifloxacin using NBD-Cl reagent, respectively. The detection limits were found to be 7.0 ng mL(-1) for ciprofloxacin, 8.5 ng mL(-1) for enoxacin, 9.2 ng mL(-1) for norfloxacin and 9.98 ng mL(-1) for moxifloxacin, respectively. Intra-day and inter-day relative standard deviation and relative mean error values at three different concentrations were determined. The low relative standard deviation values indicate good precision and high recovery values indicate accuracy of the proposed methods. The method is highly sensitive and specific. The results obtained are in good agreement with those obtained by the official and reference method. The results presented in this report show that the applied spectrofluorimetric method is acceptable for the determination of the four FQ in the pharmaceutical preparations. Common excipients used as additives in pharmaceutical preparations do not interfere with the proposed method.     

Spectrofluorimetric determination of clioquinol in pharmaceutical preparations

Summary The absorption spectrum of the nitrate radical (NO₃) in aqueous solution and the kinetic of the reactions with Cl^– and OH^– have been determined using laser-spectrometric techniques. The maximum absorption was found at 635 nm with a decadic absorption coefficient of =(530±110) l/mol·cm. At 298 K rate constants of k₁=(1.0±0.2)·10⁷ l/mol·s for the reaction with chloride and of k₂=(8.2±0.9)·10⁷ l/mol·s for the reaction with hydroxide were obtained.     

Colorimetric determination of pyridoxine in pharmaceutical preparations

Summary The USP method for the determination of pyridoxine hydrochloride in pharmaceutical preparations has been modified to increase the stability of the colour, the speed of determination and the sensitivity. The reaction is carried out in propan-2-ol medium instead of water triethanolamine is used as the buffer, and iodine is used as oxidant when necessary. The colour is stable for about 45 min, the sensitivity of the reaction is greatly increased and the method takes only about a fifth of the time of the USP method.

---

Kolorimetrische Bestimmung von Pyridoxin in pharmazeutischen Präparaten

Zusammenfassung Die USP-Methode zur Bestimmung von Pyridoxinhydrochlorid in pharmazeutischen Präparaten wurde modifiziert, um die Beständigkeit der Farbe, die Geschwindigkeit der Bestimmung und deren Empfindlichkeit zu verbessern. Statt in Wasser wird die Reaktion in Propan-2-ol durchgeführt, wobei Triethanolamin als Puffer und Jod — wenn nötig — als Oxydationsmittel verwendet werden. Die Farbe ist ungefähr 45 min beständig, die Empfindlichkeit der Reaktion stark verbessert und die zur Durchführung der Methode erforderliche Zeit beträgt etwa ein Fünftel im Vergleich zur USP-Methode.

     

Polarographic determination of chlorhexidine in pharmaceutical preparations

The electroreduction of chlorhexidine has been studied by d.c, a.c. and pulse polarography. Polarograms of the drug recorded from ammonium acetate buffers exhibit a single well-defined wave. The current is diffusion-controlled and proportional to the concentration. The reduction wave is due to an irreversible 8-electron reduction of the four> C=NH groups in the molecule to amino groups. The drug is strongly adsorbed on the electrode surface over a considerable potential range. Hence, the drug can be determined by polarography in the presence of other weaker surfactants often present in pharmaceutical formulations. Procedures have been proposed for pulse-polarographic determination of the drug in antiseptic cream and liquids. The proposed method is simple and accurate and does not involve time-consuming separation of the drug from insoluble constituents present in the sample.